Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Chu

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)Mark M Awad, Quincy S-C Chu, Leena Gandhi, et al.
Investigational New Drugs|December 19, 2013
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumoursLot A Devriese, Kevin M Koch, Marja Mergui-Roelvink, et al.
British Journal of Cancer|September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancerA C Mita, K Papadopoulos, M J A de Jonge, et al.
Genome Biology|February 5, 2013
Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signalingMichael Clarke, Amanda J Lohan, Bernard Liu, et al.
Nature Medicine|February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trialBenjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
JAMA Ophthalmology|February 26, 2026
Domain-Shift AI Technology for Vendor-Agnostic Multiple Macular Disease Detection From 3D OCT ScansZi Qi Tang, Yu Han Zhang, An Ran Ran, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Current Oncology (Toronto, Ont.)|July 28, 2023
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLCParneet K Cheema, Shantanu O Banerji, Normand Blais, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)Mark M Awad, Quincy S-C Chu, Leena Gandhi, et al.
Investigational New Drugs|December 19, 2013
Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumoursLot A Devriese, Kevin M Koch, Marja Mergui-Roelvink, et al.
British Journal of Cancer|September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancerA C Mita, K Papadopoulos, M J A de Jonge, et al.
Genome Biology|February 5, 2013
Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signalingMichael Clarke, Amanda J Lohan, Bernard Liu, et al.
Nature Medicine|February 13, 2024
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trialBenjamin Besse, Elvire Pons-Tostivint, Keunchil Park, et al.
Leukemia & Lymphoma|August 25, 2012
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working GroupArjan A van de Loosdrecht, Robin Ireland, Wolfgang Kern, et al.
JAMA Ophthalmology|February 26, 2026
Domain-Shift AI Technology for Vendor-Agnostic Multiple Macular Disease Detection From 3D OCT ScansZi Qi Tang, Yu Han Zhang, An Ran Ran, et al.
Pageof 9